On the other hand, several metastatic lines—including IGR37—regained significant expression of TRPM1 and showed reduced expression of KCNMA1, KCNN4, and TRPM2, compared to the primary melanoma lines (Figure 11, third row). The gene discussed is TRPM2; the disease is melanoma.